Radiotherapy for residual and recurrent foci after surgery for thyroid gland cancer / 中华放射肿瘤学杂志
Chinese Journal of Radiation Oncology
;
(6)1992.
Article
in Chinese
| WPRIM
| ID: wpr-551467
ABSTRACT
Purpose:
To evaluate the effect of radiotherapy and to detect the prognostic factors for residual and recurrent foci after surgery of thyroid gland cancers. Materials andMethods:
109 patients with residual or recurrent foci of thyroid cancers after surgery were treated with radiotherapy.Results:
The overall 5-,10-, 15-, 20- and 25- year survival rates were 93.6%, 91.7% , 88.7%, 87.6% and 87.6% and the 5-, 10-, 15-, 20- and 25- year survival rates with no evidence of disease were 90.8%, 89.8% ,85.6%, 84.1% and 84.1%, respectively. The clinical stage was the main factor and patient's age at diagnosis, patient's sex, histopathological types and radiation dose were also the prognostic factors.Conclusion:
Radiotherapy is beneficial to residual and recurrent foci after surgery of thyroid cancer. The optimum radiation dose is 45~65 Gy.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
Chinese
Journal:
Chinese Journal of Radiation Oncology
Year:
1992
Type:
Article
Similar
MEDLINE
...
LILACS
LIS